 |
2-[(4S)-6-(4-chlorophenyl)-1,7,8-trimethylthiophenol[3,2-f]1,2,4-triazolo[4,3-a]1,4-diazepin-4-yl]-N-[3-(4-methylpiperazinyl)propyl]acetamide |
|---|---|
| Trade Name | |
| Orphan Indication | Nuclear protein in testis (NUT) midline carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-09-29 00:00:00 |
| Sponsor | Genentech, Inc (a Roche Group Member);1 DNA Way, M/S# 35-5e;South San Francisco, California, 94080 |
